Evidence map›Paper›PMID 38560602›Full record

ArticleOpen forum infectious diseases2024

Risk of Primary Incident Hepatitis C Infection Following Bacterial Sexually Transmissible Infections Among Gay and Bisexual Men in Australia From 2016 to 2020.

Brendan L Harney, Rachel Sacks-Davis, Paul Agius, Daniela K van Santen, Michael W Traeger, Anna L Wilkinson, Jason Asselin, Christopher K Fairley, Norman Roth, Mark Bloch and 6 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Brendan L HarneyDisease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0001-9288-6942
Rachel Sacks-DavisDisease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia.ORCID https://orcid.org/0000-0003-0860-2762
Paul AgiusDisease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia.
Daniela K van SantenDisease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia.
Michael W TraegerDisease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia.
Anna L WilkinsonDisease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia.
Jason AsselinDisease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia.
Christopher K FairleyAlfred Health, Melbourne Sexual Health Centre, Melbourne, Victoria, Australia.
Norman RothPrahran Market Clinic, Melbourne, Victoria, Australia.
Mark BlochHoldsworth House Medical Practice, Sydney, New South Wales, Australia.
Gail V MatthewsKirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
Basil DonovanKirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
Rebecca GuyKirby Institute, University of New South Wales, Sydney, New South Wales, Australia.
Mark StoovéDisease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia.
Margaret E HellardDisease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia.
Joseph S DoyleDisease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia.
Burnet Institute · AUUNSW Sydney · AUHarvard University · USMelbourne Clinic · AUMelbourne Sexual Health Centre · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In Australia, the incidence of hepatitis C virus (HCV) has declined among gay and bisexual men (GBM) with human immunodeficiency virus (HIV) since 2015 and is low among GBM using HIV preexposure prophylaxis (PrEP). However, ongoing HCV testing and treatment remains necessary to sustain this. To assess the potential utility of sexually transmissible infections (STIs) to inform HCV testing among GBM with HIV and GBM using PrEP, we examined the association between bacterial STI diagnoses and subsequent primary HCV infection. Methods: Data were from a national network of 46 clinics participating in the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance. GBM included had ≥1 HCV antibody negative test result and ≥1 subsequent HCV antibody and/or RNA test. Discrete time survival analysis was used to estimate the association between a positive syphilis, rectal chlamydia, and rectal gonorrhea diagnosis in the previous 2 years and a primary HCV diagnosis, defined as a positive HCV antibody or RNA test result. Results: Among 6529 GBM with HIV, 92 (1.4%) had an incident HCV infection. A prior positive syphilis diagnosis was associated with an incident HCV diagnosis (adjusted hazard ratio, 1.99 [95% confidence interval, 1.11-3.58]). Among 13 061 GBM prescribed PrEP, 48 (0.4%) had an incident HCV diagnosis. Prior rectal chlamydia (adjusted hazard ratio, 2.75 [95% confidence interval, 1.42-5.32]) and rectal gonorrhea (2.54 [1.28-5.05]) diagnoses were associated with incident HCV. Conclusions: Diagnoses of bacterial STIs in the past 2 years was associated with HCV incidence. These findings suggest that STIs might be useful for informing HCV testing decisions and guidelines for GBM with HIV and GBM using PrEP.

Indexed as

chlamydiagonorrheahepatitis CHIVsyphilis

Identifiers

PMID38560602
PMCPMC10977630
OpenAlexW4391925797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.